Wolverine Trading’s iBio IBIO Stock Holding History

Wolverine Trading’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23	Closed	-$13K	–	6102
2020 Q4	$13K	Buy	+23	New	+$18.7K	﹤0.01%	4708

Other funds holding IBIO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wolverine Trading's IBIO Position: Q1 2021 in Review

Wolverine Trading sold out of iBio (IBIO) in Q1 2021, closing a stake of 23 shares — an estimated $13K sold.

Wolverine Trading first reported a position in IBIO in Q4 2020 and held it in 1 quarter. The position peaked at $13K in Q4 2020. 91 funds tracked by Wall St. Rank hold IBIO as of Q1 2021.

Wolverine Trading reported no remaining iBio position as of Q1 2021 after selling out during the quarter.
Wolverine Trading sold 23 iBio shares in Q1 2021, an estimated $13K.
Wolverine Trading first reported a position in iBio in Q4 2020 and held it in 1 quarter.
Wolverine Trading's iBio position peaked at $13K in Q4 2020.
91 funds tracked by Wall St. Rank held iBio as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.